Prescription drug · ANDA
Rosuvastatin NDC 33342-264
Rosuvastatin calcium 40 mg/1 · Tablet · Oral · Macleods Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 33342-264-07 | 33342026407 | 30 TABLET in 1 CONTAINER (33342-264-07)Marketed from Nov 6, 2024 | |
| 33342-264-10 | 33342026410 | 90 TABLET in 1 CONTAINER (33342-264-10)Marketed from Nov 6, 2024 | |
| 33342-264-12 | 33342026412 | 10 BLISTER PACK in 1 CARTON (33342-264-12) / 10 TABLET in 1 BLISTER PACKMarketed from Nov 6, 2024 | |
| 33342-264-44 | 33342026444 | 1000 TABLET in 1 CONTAINER (33342-264-44)Marketed from Nov 6, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rosuvastatin
- Generic name (nonproprietary)
- rosuvastatin
- Active ingredients
- Rosuvastatin calcium — 40 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Macleods Pharmaceuticals LimitedNDC labeler code 33342
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207296
- Marketing start
- Listing expires
- Other FDA classes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 33342-264_093ea34a-0a0b-4642-8e8e-62d6fc5c37d4SPL ID 093ea34a-0a0b-4642-8e8e-62d6fc5c37d4SPL set ID d7b9f280-bda6-40d4-9778-e45efb87ab23RxCUI 859419, 859424, 859747, 859751UNII 83MVU38M7QUPC 0333342261441
- Pharmacologic class
- HMG-CoA Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N433342026407followed by a unit qualifier and the quantityPackage 33342-0264-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Rosuvastatin tablets are indicated: • To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults at increased risk for CV events. • As an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C): o in adults with hypercholesterolemia. o and slow the progression of atherosclerosis in adults. o in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (He FH). o in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (Ho FH). • As an adjunct to diet for the trea…
Excerpt only. Read the full label for complete information.
About NDC 33342-264
- What is NDC 33342-264?
- 33342-264 is the product NDC for Rosuvastatin, Rosuvastatin calcium 40 mg/1 tablet, listed with the FDA by Macleods Pharmaceuticals Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Rosuvastatin.
- What is the active ingredient?
- Rosuvastatin calcium.
- Who is the labeler?
- Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Rosuvastatin?
- 64 other product NDCs are listed under this name. See all Rosuvastatin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Rosuvastatin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Rosuvastatin | Rosuvastatin 5 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | 68788-4161 | 68788-4161-0368788-4161-0668788-4161-09 |
| Rosuvastatin | Rosuvastatin calcium 5 mg/1 | Tablet, CoatedOral | AiPing Pharmaceutical, Inc. | 11788-130 | 11788-0130-0511788-0130-1011788-0130-90 |
| Rosuvastatin | Rosuvastatin calcium 10 mg/1 | Tablet, CoatedOral | AiPing Pharmaceutical, Inc. | 11788-131 | 11788-0131-0511788-0131-1011788-0131-90 |
| Rosuvastatin | Rosuvastatin calcium 20 mg/1 | Tablet, CoatedOral | AiPing Pharmaceutical, Inc. | 11788-132 | 11788-0132-0511788-0132-1011788-0132-90 |
| Rosuvastatin | Rosuvastatin calcium 40 mg/1 | Tablet, CoatedOral | AiPing Pharmaceutical, Inc. | 11788-133 | 11788-0133-0511788-0133-1011788-0133-90 |
| Rosuvastatin | Rosuvastatin 10 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-1627 | 67046-1627-03 |
| Rosuvastatin | Rosuvastatin calcium 5 mg/1 | Tablet, Film coatedOral | Quallent Pharmaceuticals Health LLC | 82009-188 | 82009-0188-05 |
| Rosuvastatin | Rosuvastatin calcium 10 mg/1 | Tablet, Film coatedOral | Quallent Pharmaceuticals Health LLC | 82009-189 | 82009-0189-05 |
| Rosuvastatin | Rosuvastatin calcium 20 mg/1 | Tablet, Film coatedOral | Quallent Pharmaceuticals Health LLC | 82009-190 | 82009-0190-05 |
| Rosuvastatin | Rosuvastatin calcium 40 mg/1 | Tablet, Film coatedOral | Quallent Pharmaceuticals Health LLC | 82009-191 | 82009-0191-05 |
Other NDCs under ANDA 207296
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rosuvastatin | Rosuvastatin calcium 5 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-261 |
| Rosuvastatin | Rosuvastatin calcium 10 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-262 |
| Rosuvastatin | Rosuvastatin calcium 20 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-263 |